Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012753 · ClinicalTrials.gov registry record · Phase 3
Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 272
- Enrollment target
NCT00012753: Completed Phase 3 study, sponsored by US Department of Veterans Affairs.
NCT00012753 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 272 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012753, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 272 participants
- Enrollment target
Study Summary
Regular outpatient follow-up is important for all diabetes patients, with some needing frequent attention because their health is unstable, their treatment regimen is complex, or their social supports are inadequate. However, many patients live with access barriers that limit their use of outpatient services, fail to attend outpatient appointments, and experience worse outcomes than trials of aggressive management suggest is possible. Although labor-intensive, telephone care programs are one potential strategy for bringing diabetes management services into patients� homes and improving their glycemic control. Automated telephone disease management (ATDM) systems can augment telephone care by providing frequent monitoring and health education to large patient panels while focusing clinicians� attention on individuals who need it most. Although this technology has shown some promise, it has not been rigorously evaluated, particularly in VA.
Interventions
- PROCEDURE Automated telephone health status assessments with nurse follow-up.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Est. Completion | 1999-12 |
| Phase | Phase 3 |
What the finished NCT00012753 record still lists
NCT00012753 is an interventional study that assigns participants to a tested intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Automated telephone health status assessments with nurse follow-up. is the first listed.
NCT00012753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012753 about?
NCT00012753 is a clinical study titled "Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care". Regular outpatient follow-up is important for all diabetes patients, with some needing frequent attention because their health is unstable, their treatment regimen is complex, or their social supports are inadequate. However, many patients live with access barriers that limit their use of outpatient...
What is the current status of trial NCT00012753?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 272 participants. Estimated completion is 1999-12.
What interventions are being tested in trial NCT00012753?
The interventions under investigation include: Automated telephone health status assessments with nurse follow-up. (PROCEDURE).
Who is sponsoring clinical trial NCT00012753?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00012753's enrollment target sits among peer trials
272 1214th of 2000 higher than 785 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06083051 · 272 participants · NA
Differences in Postoperative Symptoms With Four Ureteral Stents